The weekly litigation news digest is live. Subscribe now

IP Verse

Merial competitive analysis

Loading summary...

Latest patents of Merial opposed by its competitors

Explore Merial's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2785374
Aug 17, 2022Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof1
EP2998315
Nov 3, 2021Newcastle Disease Virus Vectored Avian Vaccines1
EP3061454
Mar 10, 2021Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof2
EP3167900
Nov 21, 2018Vaccine Against Streptococci1
EP2874653
Dec 27, 2017Method Of Providing Protective Immunity Against Heterologous Leptospira Strains1

Latest PTAB cases involving Merial

Discover the latest PTAB cases involving Merial, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 16, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merial

IPR2018-00919Apr 13, 2018MERIALINTERVETInstitution Denied
IPR2016-01182Jun 10, 2016MERIALFIDOPHARMTerminated-Settled
IPR2016-00798Mar 25, 2016MERIALSERGEANTS PET CARE PRODUCTSInstitution Denied
IPR2015-00254Nov 10, 2014BIOMUNEMERIALFinal Written Decision
IPR2014-01279Aug 14, 2014MERIALVIRBACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Merial with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERIAL - 641
BIOMUNE - - 1 -
FIDOPHARM - - - 1
INTERVET113641